Literature DB >> 10679121

Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients.

M Colombo1, M Dono, P Gazzola, S Roncella, A Valetto, N Chiorazzi, G L Mancardi, M Ferrarini.   

Abstract

The accumulation of B lymphocyte clones in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) and patients with other neurological disorders was investigated using PCR technologies. Oligoclonal B cell accumulations were detected in 10 of 10 MS patients, but only in 3 of 10 of the patients with other neurological disorders. Analyses of the Ig V(D)J sequences on the CSF from MS patients disclosed that VH3 and VH4 genes were extensively mutated compared with germline sequences. Moreover, a substantial proportion of the molecular clones analyzed shared the same third CDR of the H chain variable region gene (HCDR3) and the same VH genes, albeit with different numbers and locations of point mutations, thus indicating an ongoing process of intraclonal diversification. A larger number of clonally related VH sequences could be obtained by using a VH3 gene-specific PCR so that genealogical trees depicting the process of diversification could be drawn. Analyses of the Ig V(D)J from the CSF of a patient with viral meningitis and oligoclonal B cell accumulations revealed that VH3 genes were extensively mutated. However, no intraclonal diversification could be observed even using VH3 gene-specific PCR methodologies. Clone-specific PCR and sequencing was used to detect the V(D)J found in the CSF of one MS patient in the PBL of the same patient. Only 1/3 of the V(D)J sequences investigated could be demonstrated in the PBL, indicating that the V(D)J genes utilized by B cells in the CSF are much less represented in the PBL. Collectively, the data suggest that in MS there is a compartmentalized clonal expansion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679121     DOI: 10.4049/jimmunol.164.5.2782

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 2.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

Review 3.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

4.  Polyclonal B-cell expansion in the cerebrospinal fluid of patients with pseudotumor cerebri.

Authors:  Reng-Rong Da; Grace Kao; Wen-Zhong Guo; Michael Olek; Sudhir Gupta; Yiping Zhang; Stanley Van Den Noort; Yufen Qin
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

Review 5.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.

Authors:  Christopher Harp; Jane Lee; Doris Lambracht-Washington; Elizabeth Cameron; Gregory Olsen; Elliot Frohman; Michael Racke; Nancy Monson
Journal:  J Neuroimmunol       Date:  2006-12-13       Impact factor: 3.478

Review 7.  Epstein-barr virus: environmental trigger of multiple sclerosis?

Authors:  Jan D Lünemann; Thomas Kamradt; Roland Martin; Christian Münz
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 8.  B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.

Authors:  Angela Lee Foreman; Judy Van de Water; Marie-Lise Gougeon; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2007-01-12       Impact factor: 9.754

9.  CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome.

Authors:  Jeffrey L Bennett; Kurt Haubold; Alanna M Ritchie; Sydni J Edwards; Mark Burgoon; Andrew J Shearer; Donald H Gilden; Gregory P Owens
Journal:  J Neuroimmunol       Date:  2008-06-10       Impact factor: 3.478

Review 10.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.